Original Article

Duration of benign paroxysmal positional vertigo as a predictor for therapy

Volume 11 · Issue 3 Publish Date: September 15, 2015
Full Text PDF
D. G. Balatsouras
ENT Department, Tzanion General Hospital, Pireaus, Greece
A. Aspris
ENT Department, Nicosia General Hospital, Nicosia, Cyprus
P. Ganelis
ENT Department, Tzanion General Hospital, Pireaus, Greece
G. Koukoutsis
ENT Department, Tzanion General Hospital, Pireaus, Greece
A. Moukos
ENT Department, Tzanion General Hospital, Pireaus, Greece
A. Fassolis
ENT Department, Tzanion General Hospital, Pireaus, Greece
M. Katotomichelakis
ENT Department, Medical School, Democritus University of Thrace, Alexandroupolis, Greece
Balatsouras, D. G., Aspris, A., Ganelis, P., Koukoutsis, G., Moukos, A., Fassolis, A., & Katotomichelakis, M. (2015). Duration of benign paroxysmal positional vertigo as a predictor for therapy. B-ENT, 11(3), 199–203. Retrieved from https://www.b-ent.be/index.php/pub/article/view/590
Full Text Full Text PDF

Abstract

Duration of benign paroxysmal positional vertigo as a predictor for therapy. Objective: To evaluate the prognostic significance of the duration of disease in patients with benign paroxysmal positional vertigo (BPPV). Methods: We studied all patients with idiopathic BPPV of the posterior semicircular canal who were treated during 3 consecutive years, divided into 2 groups: those with recent disease onset (within 4 weeks) and those with more remote disease onset. Outcome of treatment by repositioning maneuver and rate of recurrence were compared. Results: 110 patients had BPPV of recent onset and 121 of more remote onset (mean ages 51.3 and 58.2, respectively). Treatment outcomes were similar in both groups, but the rate of recurrence was higher in patients with BPPV of longer duration (21.5% versus 10%). Conclusion: Long duration of the disease does not affect the treatment outcome in patients with idiopathic BPPV, but is correlated with increased rate of recurrence. Older age of these patients is probably a contributing factor for recurrence.

Similar Articles

Article Info
Published In
Journal B-ENT
Volume / Issue Volume 11 · Issue 3
Pages 199-203
History
Published Online September 15, 2015
Affiliations
D. G. Balatsouras
ENT Department, Tzanion General Hospital, Pireaus, Greece
A. Aspris
ENT Department, Nicosia General Hospital, Nicosia, Cyprus
P. Ganelis
ENT Department, Tzanion General Hospital, Pireaus, Greece
G. Koukoutsis
ENT Department, Tzanion General Hospital, Pireaus, Greece
A. Moukos
ENT Department, Tzanion General Hospital, Pireaus, Greece
A. Fassolis
ENT Department, Tzanion General Hospital, Pireaus, Greece
M. Katotomichelakis
ENT Department, Medical School, Democritus University of Thrace, Alexandroupolis, Greece
Cite this Article
Balatsouras, D. G., Aspris, A., Ganelis, P., Koukoutsis, G., Moukos, A., Fassolis, A., & Katotomichelakis, M. (2015). Duration of benign paroxysmal positional vertigo as a predictor for therapy. B-ENT, 11(3), 199–203. Retrieved from https://www.b-ent.be/index.php/pub/article/view/590
Outlines